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Abstract: Aims: Stachys lavandulifolia Vahl is a frequently used plant to treat different diseases, but its prob-
able toxic effects have not been reported yet. This study aimed to study the toxicity of the extract on rats’ liver. 
Methods: In this experimental study, 100 rats were designated into 10 groups and injected normal saline or Stachys 
lavandulifolia Vahl extract at 50, 100, 150, and 200 mg/kg, intraperitoneally for 28 days. Four case groups and one con-
trol group were examined for ALT, AST and ALP after one month and the other groups were evaluated after two months.
Results: In the fi rst month, the increase of ALP at all doses and the increase of AST at 200 mg/kg was signifi -
cant, compared to the control group (p<0.05). In the second month, AST increased at the dosage of 150mg/
kg, and ALP decreased at the dosage of 100 mg/kg, compared to the control group (p<0.05). Histopathological 
assessment showed a signifi cant dose dependent increase both in necrotic-infl ammatory reactions and fi brotic 
lesions, in the fi rst and second months, compared to the control group (p<0.001). 
Conclusions: The Stachys lavandulifolia extract injected intraperitoneally has hepatotoxic effect, which is not elimi-
nated by the drug withdrawal. Therefore, it is necessary to be consumed with caution (Tab. 4, Fig. 1, Ref. 21).
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Liver is one of the most important organs for absorption, metab-
olism and excretion of drugs and other harmful substances. There-
fore, it is subject to toxic effects of the drugs and different substances.
Several biochemical tests are used to diagnose the liver diseas-
es. The most important of these tests are serum aminotransferases 
(ALT, AST) that are indicators of hepatocyte damage. Increasing 
of their activities usually indicate the presence of an active liver 
disease. Alkaline phosphatase (ALP) is increased in diseases re-
lated to the secretion and excretion of bile (cholestatic diseases) (1). 
Medicinal plants play a central role as traditional medicine for their 
therapeutic or preventive effects against drug or chemical toxicities 
(2–5), however, some herbs, which even have been used traditionally 
might have acute or chronic toxicity. Among the plants that might      have 
liver toxicity based on the traditional beliefs of people in Chaharmahal 
and Bakhtiari (a province in Iran), is Stachys lavandulifolia (1). This 
plant is from the family of Laminacea, which is known as Betony in 
English (Wooly Betony, Lamb’s ear, Woundwort or Oulileh, in Per-
sian) (6–8). The active components of this plant include phenyletha-
noids, terpenoids and fl avonoids (7). 
This plant is a stomach tonic (1) and is taken to treat infections, 
asthma and rheumatic diseases (9). Betony has anxiolytic effects 
(1) and is useful in the treatment of genital tumors, skin cancer and 
infl ammation (7). The anti-microbial effects of this plant against 
Streptococcus sanguis are also recognized. The extract of this plant 
has shown to have analgesic and anti-infl ammatory activities in 
dosages of 50–200 mg/kg (11). 
In the study, the extract of this plant had not have any effect on 
embryonic development and had not caused any abnormalities in 
rat (12), yet in another study, it was shown to induce abortion (13).
Regarding the fact that Stachys lavandulifolia Vahl is fre-
quently used to treat different diseases and its liver toxicity has 
not been examined in users yet, this study aimed to evaluate the 
probable toxicity of this extract on rat’s liver.
Materials and methods
Extraction Method
In this study, the aerial parts of Stachys lavandulifolia Vahl 
were collected from Hafshejan, a city in Chaharmahal and Bakhtiari 
province of Iran. A specimen was deposited in the herbarium unit 
of the Medical Plants Research Center of Shahrekord University 
of Medical Sciences, after being authenticated by the botanist 
expert (herbarium no. 204). After passing the drying process in 
shadow at 37° centigrade, the extracting process was carried out 
by maceration method using 80 % ethanol. In order to prepare the 
extract, 500cc of 80 % ethanol was poured on 100 grams of the 
plant powder and was fi ltered after 72 hours. The obtained extract 
was transferred to the vacuum distillation apparatus (rotary) and 
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concentrated to one third of the initial value. Then the extract was 
dried by oven at 40° centigrade and four different concentrations 
were prepared for study. 
Standardization of the extract 
To standardize Stachys lavandulifolia extract, its total phenolic 
and fl avonoid components were measured as follows:
The phenolic compounds were measured equivalent to gallic 
acid using Folin-Ciocalteu colorimetry as previously described by 
Shirzad and coworkers (14), with some modifi cations. Different 
concentrations of standard gallic acid (12.5, 25, 50, 62.5, 100 and 
125 ppm in methanol 60 %) were prepared. Then, 0.1 ml from each 
sample was transferred into a test tube and 0.5 ml Folin-Ciocalteu 
10 % was added as reactive agent. The solutions were left for 8 
minutes at a room temperature and then 0.4 ml sodium carbon-
ate 7.5 % was added. The tubes were maintained for 30 min at 
the laboratory temperature and then assayed in three intervals by 
a spectrophotometer (Unico uv 2010) at 765 nm wavelength. To 
measure the overall phenol in the extracts, 0.01–0.02 g of the ex-
tracts was dissolved in 60 % methanol, reaching 10 ml and then, 
the overall level of phenol was measured. However, instead of 
using the standard solution, 0.1 ml extract solution was added. 
Finally, the overall phenol level was obtained from the read opti-
cal density in mg/g extract in gallic acid equivalent.
Total fl avonoids were measured equivalent to Rutin, using 
Chloride aluminum colorimetry and Rutin methods, as previously 
described by Kazemi and coworkers (15), with a slight modifi ca-
tion. First, different concentrations of standard “Rutin” (25, 50, 
100, 250 and 500 ppm) were prepared in methanol 60 %. Then, 
from each solution, a ml was transferred into test tubes and mixed 
with 1 ml of chloride aluminum 2 %. Afterwards, 6 ml potassium 
acetate 5 % was added and the optical density level was read af-
ter 40 minutes at 415 nm wavelength. The concentration levels of 
the standard solutions were assayed in three intervals. In order to 
measure the overall level of fl avonoids in the extracts, 0.01–0.02 
g of the extracts was dissolved in methanol 60 %, reaching 10 
ml. Then, using chloride aluminum colorimetry, the total level of 
fl avonoids was measured. However, instead of using the standard 
solution, 1 ml of the extract was added. The total fl avonoid level 
was calculated in mg per one gram extract, equivalent to Rutin.
The total fl avonol was also measured using chloride aluminum 
colorimetry and Rutin procedure, however, the optical density level 
reading, was obtained after 2.5 hours at 440 nm wavelength (16).
Interventional procedure 
In this experimental study, 100 rats at 8–12 weeks of age, 
weighing approximately 250 grams were placed randomly in 10 
groups of 10 members, including 2 control and 8 case groups. The 
animals were kept at 22–25 °C in normal condition (darkness and 
light) and normal feeding. 
The herbal extract was injected intraperitoneally for one month, 
at the dosages of 50, 100, 150, and 200mg/kg to the 8 case groups 
(each concentration was injected to two groups). During this period 
of time, 0.3ml of normal saline was injected to each rat of the two 
control groups. At the end of the fi rst month, samples were taken 
from 4 case groups and one control group, considering medical eth-
ics and under general anesthesia. Moreover, at the end of the second 
month, specimens were taken from the other groups to measure 
the levels of liver enzymes including Alanine Aminotransferase 
(ALT), Aspartate Aminotransferase (AST) and Alkaline Phospha-
tase (ALP) in order to analyze the effect of time on the improve-
ment of the plant resulted complications. Histopathological tests 
were done on samples through autopsy and taking liver samples.
Knodell-Ishak scoring system was used in this study in order 
to measure the amount of infl ammation and fi brosis in the liver 
tissue (17).
The data were described by the mean and standard deviation 
(SD) by SPSS 11.5 software and were analyzed using ANOVA, 
Scheffe, Kruskal-Wallis, Dunn and Mann–Whitney tests.
Results
Total fl avonoid, fl avonol and phenolic contents of Stachys Lavan-
dulifolia Vahl
The total phenolic content of Stachys Lavandulifolia Vahl was 
443.3±8.1 mg gallic acid equivalent/g, its total fl avonoid content 
was 176±2.9 mg Rutin equivalent/g, and the total fl avonol content 
was 132.7±13.1 mg Rutin equivalent/g dry extract. 
Effect of the extract on rats’ liver enzymes
Effect of the extract on rats’ liver enzymes in the fi rst month 
is presented in Table 1. There was a signifi cant difference in the 
mean of ALT levels at all doses and AST at the dose of 200 mg/
kg in comparison with the control group. No signifi cant difference 
was observed in any of the case groups regarding the change in 
liver enzymes (p>0.05). 
The effect of Stachys lavandulifolia Vahl hydro-alcoholic ex-
tract on liver enzymes in the second month is presented in Table 
2. In the second month, the mean of ALT and AST had a signifi -
cant difference at doses 50, 150, and 200 mg in comparison with 
the control group. None of the groups had signifi cant difference 
Groups
Mean±SD
AST ALT ALP
Control 151.60±94.21 92.00±64.37 125.40±49.89
50 mg/kg 236.10±196.84 101.30±52.35 **723.70±195.95
100 mg/kg 386.90±275.2 131.30±79.13 **621.80±144.73
150 mg/kg 306.80±346.26 174.70±142.19 **729.40±221.88
200 mg/kg *508.10±156.99 180.80±99.44 **554.60±188.28
** p<0.001, * p<0.05, in comparison with the control group (n=10)
Tab. 1. Effect of Stachys lavandulifolia Vahl hydro-alcoholic extract 
on rats’ liver enzymes in the fi rst month.
Groups
Mean±SD
AST ALT ALP
Control 162.30±84.79 96.00±53.25 131.50±54.17
50 mg/kg *334.00±136.82 181.50±186.97 *323.50±133.94
100 mg/kg 185.60±135.08 147.10±109.09 232.80±111.99
150 mg/kg *347.50±179.66 210.90±229.21 **418.60±136.45
200 mg/kg *360.10±93.26 82.60±19.14 **414.30±182.20
**p<0.001, *p<0.05, in comparison with the control group (n=10)
Tab. 2. Effect of Stachys lavandulifolia Vahl hydro-alcoholic extract 
on rats’ liver enzymes at the end of the second month.
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regarding liver enzymes (p>0.05), except for the dose of 150 mg/
kg that had a signifi cant difference regarding ALP compared to 
the dose of 100 mg/kg (p<0.05). Comparison results of the fi rst 
and second month of each of the four doses, regarding the liver 
enzymes, are presented in Table 3.
Histopathological results
Histopathological assessment of rats’ liver tissue showed no 
considerable pathological differences in the control group. Histo-
pathological assessment of liver tissue in rats, receiving the extract 
at four mentioned doses showed a signifi cant difference both in 
necrotic-infl ammatory reactions and fi brotic lesions, in the fi rst and 
the second months using the Mann–Whitney test in comparison 
with the control group (p<0.001). 
In the fi rst month, there was a signifi cant difference between 
the groups receiving the Stachys lavandulifolia Vahl extract with 
doses of 50 and 150; 50 and 200; 100 and 150; 100 and 200 mg/
kg, both in necrotic–infl ammatory reactions and fi brotic lesions 
using Dunn’s test (p<0.05) (Fig. 1). As it is clear in the diagram, 
a considerable difference was observed between the doses 50 or 
100 and doses 150 and 200 mg/kg.
In the second month, no signifi cant differences were observed 
in necrotic–infl ammatory reactions or fi brotic reactions in the four 
groups of rats (p>0.05) (Dunn’s test).
The mean of necrotic–infl ammatory reactions in the second 
month decreased in comparison with the fi rst month in the group 
receiving the dose of 200mg/kg of the extract. However, the mean 
of fi brotic lesions increased in the second month in comparison 
with the fi rst month, in the group receiving the dose of 100mg/kg 
of the extract (p<0.05) (Tab. 4).
Discussion
This study aimed to evaluate the toxicity of Stachys lavandu-
lifolia Vahl extract on rats’ liver. 
A signifi cant increase in ALP and AST was observed follow-
ing Stachys lavandulifolia Vahl usage. Histopathological assess-
ment also showed a signifi cant dose dependent increase both in 
necrotic–infl ammatory reactions and fi brotic lesions, in the fi rst 
and the second month compared to the control group. 
Few studies have been performed on the toxic effects of Stachys 
lavandulifolia Vahl. However, Stachys byzantina has been shown to 
have cytotoxic effects (18). Abortive effect of Stachys lavandulifolia 
Vahl has also been reported in in mice (13), but no report was found 
on the probable toxicity of Stachys lavandulifolia Vahl on the liver.
At the end of the fi rst month, all groups, which received dif-
ferent doses of the extract, showed a considerable ALP increase 
in comparison with the control group. This increase was probably 
due to its toxic effect on bile duct cells or hepatocyte canalicular 
membrane (19). It can be concluded that the safe dosage of this 
drug should probably be under 50 mg/kg in this case. 
At the end of the second month (i.e. one month after stopping 
the injection of the extract), ALP showed a considerable increase 
in comparison with the control group, at 50, 150, and 200 mg/kg 
doses (due to an unclear reason, the dose of 100 mg/kg was not 
signifi cant in this regard). It means that even one month after the 
stopping the extract injection, its toxic effect on bile duct epithelial 
cells and hepatocyte canalicular membrane remained unchanged. 
At the end of the fi rst month, AST had a signifi cant increase 
at the dose of 200 mg/kg (highest dose), in comparison with the 
control group. The relative increase of AST can imply the higher 
severity of fi brosis process in liver and this issue is consistent with 
Variable
Group
Month
Mean±SD
Control Dose 50 Dose 100 Dose 150 Dose 200
AST First 151.60±94.21 236.10±196.84 386.90±275.2 306.80±346.26 508.10±156.99Second 162.30±84.79 334.00±136.82 185.60*±135.08 347.50±179.66 *360.10±93.26
ALT First 92.00±64.37 101.30±52.35 131.30±79.13 174.70±142.19 180.80±99.44Second 96.00±53.25 181.50±186.97 147.10±109.09 210.90±229.21 **82.60±19.14
ALP First 125.40±49.89 723.70±195.95 621.80±144.73 729.40±221.88 554.60±188.28Second 131.50±54.17 ***323.50±1333.94 ***232.80±111.99 ***418.60±136.45 414.30±182.20
*p<0.05, **p<0.01, ***p<0.001 in comparison with the fi rst month, (n=10)
Tab. 3. Comparing the effect of Stachys lavandulifolia Vahl hydro-alcoholic extract on rats’ liver enzymes between the fi rst and the second month.
Fig. 1. Comparing the severity of infl ammation and necrosis in rats 
receiving four different doses (50, 100, 150 and 200mg/kg) of Stachys 
lavandulifolia Vahl extract in the fi rst month. Numbers are based on 
Mean±SEM (the maximum point for the infl ammation and necrosis=18).
 Groups 
(mg\kg)
Month Mean±SD
infl ammatory responses
Mean±SD
fi brotic lesions
50 First 4.3±3.3 1.9±1.3
Second 5.4±1.8 2.4±1.2
100 First 4.1±3.2 2.4±0.51
Second 5.6±0.81 *3.00±0.00
150 First 7.1±1.2 3.00±0.00
Second 6.4±0.69 3.00±0.00
200 First 7.00±0.00 3.00±0.00
Second *6.1±0.3 3.00±0.00
p<0.05 in comparison with the fi rst month (Mann-Whitney test)
Tab. 4. Comparing the means of necrotic-infl ammatory responses and 
fi brotic lesions between the fi rst and the second month in each of the 
four groups of rats receiving the extract.
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the creation of widespread pathological lesions at this dose, which 
means that probably higher doses might start the fi brosis process 
in a shorter time. Therefore, it can be concluded that the extract of 
Stachys lavandulifolia Vahl can have toxic effects on parenchyma 
and liver cells at the dose of 200 mg/kg. 
Although, the increase of liver enzymes in the fi rst month did 
not depend on increasing of the extract dose, referring to Table 1, 
one can fi nd a relative linear relation between increasing of the 
liver enzymes and the dose. 
AST, at the doses of 150 and 200 mg/kg, but not at lower doses, 
was increased considerably in comparison with the control group, 
which indicates that this effect is dose dependent. 
ALP, at the doses of 50, 100 and 150 mg/kg; ALT at the dose of 
200 mg/kg; AST at the doses of 100, and 200 mg/kg were consid-
erably decreased in the second month, in comparison with the fi rst 
month. It means that withdrawal of the extract consumption has giv-
en an opportunity to liver to partially regenerate (although the toxic 
effect continues). In other words, partial improvement is observed 
and may be longer follow–up reveal their return to the normal range. 
Regarding the results, a safe dose for lack of infl ammatory and 
fi brotic reactions should be under 50 mg/kg, because at the stud-
ied doses clear and signifi cant infl ammatory and fi brotic reactions 
were seen in comparison with the control group. 
As the results showed, the difference was signifi cant in the fi rst 
month between doses 50 or 100 mg/kg, and 150 or 200 mg/kg, regard-
ing the necrotic–infl ammatory reactions or fi brotic lesions, which 
means the exacerbation level of these lesions started after 100 mg/kg. 
In the second month, the mean of necrotic–infl ammatory and 
fi brotic reactions were signifi cant in four groups of rats receiv-
ing the extract in comparison with the control group. It means 
that about one month after stopping the injection of the extract, 
its toxic effect continued at all the studied doses and had caused 
the continuity of necrotic–infl ammatory and fi brotic responses. 
The cytotoxic effects of savory or Satureja genus that belong 
to the Lamiaceae family, are known as the result of terpenoid and 
especially triterpene available in them (18). One of the active 
components of Stachys lavandulifolia Vahl is also terpenoid (7, 
20, 21). Therefore, possibly at least one of the factors that caused 
the toxic effect of the Stachys lavandulifolia Vahl extract in this 
study is its terpenoid combinations. Of course, it is possible that 
other factors caused the toxic effect of the extract. Anyway, further 
studies should be done to clarify the toxic reasons of the extract of 
Stachys lavandulifolia Vahl, especially its terpenoid components.
Conclusion 
During this study, it was found that the extract of Stachys lavan-
dulifolia Vahl was able to create toxic effects in rats at the studied 
doses; therefore, the following suggestions should be mentioned: 
Patients with underlying liver diseases should take this drug 
more cautiously, especially at high doses.
Further studies should be done on less than 50mg/kg doses in or-
der to discover the determinant dosage for the hepatotoxicity onset. 
Further research is suggested to discover the mechanism of 
toxic effects of this plant. 
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